Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$617M |
| 2 |
Welltower
WELL
|
+$289M |
| 3 |
Bank of America
BAC
|
+$237M |
| 4 |
Exelon
EXC
|
+$218M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.33B |
| 2 |
Williams Companies
WMB
|
+$585M |
| 3 |
TSMC
TSM
|
+$333M |
| 4 |
Deutsche Bank
DB
|
+$288M |
| 5 |
Sempra
SRE
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.58% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 11.89% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Communication Services | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Federated Hermes
FHI
$4.8B
| $6.58M | ﹤0.01% |
163,987
-41,088
| -20% | -$1.61M |
|
1102
Zai Lab
ZLAB
$2.08B
| $6.55M | ﹤0.01% |
197,003
-112,345
| -36% | -$4.31M |
|
1103
Viridian Therapeutics
VRDN
$2.25B
| $6.46M | ﹤0.01% |
254,114
+237,028
| +1,387% | +$7.6M |
|
1104
BridgeBio Pharma
BBIO
$16.1B
| $6.43M | ﹤0.01% |
388,086
+101,938
| +36% | +$1.19M |
|
1105
Hancock Whitney
HWC
$6.34B
| $6.41M | ﹤0.01% |
176,133
+14,240
| +9% | +$665K |
|
1106
Karyopharm Therapeutics
KPTI
$45.8M
| $6.4M | ﹤0.01% |
109,662
+70,040
| +177% | +$3.46M |
|
1107
iQIYI
IQ
$1.28B
| $6.4M | ﹤0.01% |
878,812
-227,548
| -21% | -$1.56M |
|
|
CIVI
1108
DELISTED
Civitas Resources
CIVI
| $6.37M | ﹤0.01% |
93,189
+59,306
| +175% | +$3.85M |
|
1109
Dr. Reddy's Laboratories
RDY
$10.1B
| $6.37M | ﹤0.01% |
559,040
-19,500
| -3% | -$210K |
|
1110
BGC Group
BGC
$5.3B
| $6.35M | ﹤0.01% |
1,213,227
+1,060,451
| +694% | +$4.86M |
|
|
AZEK
1111
DELISTED
The AZEK Co
AZEK
| $6.3M | ﹤0.01% |
267,573
+10,483
| +4% | +$248K |
|
1112
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$782M
| $6.29M | ﹤0.01% |
171,757
-64,268
| -27% | -$2.32M |
|
|
SUMO
1113
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $6.28M | ﹤0.01% |
524,587
+198,353
| +61% | +$2.17M |
|
1114
GDS Holdings
GDS
$6.67B
| $6.25M | ﹤0.01% |
334,927
+162,699
| +94% | +$3.45M |
|
1115
Arrowhead Research
ARWR
$12.6B
| $6.21M | ﹤0.01% |
244,441
+17,751
| +8% | +$558K |
|
1116
Flywire
FLYW
$2.12B
| $6.2M | ﹤0.01% |
211,050
+181,808
| +622% | +$4.79M |
|
1117
Community Bank
CBU
$3.55B
| $6.19M | ﹤0.01% |
117,914
+2,482
| +2% | +$145K |
|
|
AYX
1118
DELISTED
Alteryx Inc
AYX
| $6.18M | ﹤0.01% |
105,017
+102,695
| +4,423% | +$5.99M |
|
1119
Hilton Grand Vacations
HGV
$3.6B
| $6.16M | ﹤0.01% |
138,713
+17,344
| +14% | +$786K |
|
|
LAZR
1120
DELISTED
Luminar Technologies
LAZR
| $6.16M | ﹤0.01% |
63,238
-3,045
| -5% | -$320K |
|
1121
Navient
NAVI
$878M
| $6.14M | ﹤0.01% |
384,009
+175,101
| +84% | +$3.05M |
|
1122
Avista
AVA
$3.31B
| $6.14M | ﹤0.01% |
144,597
-37,552
| -21% | -$1.55M |
|
1123
EnerSys
ENS
$7.1B
| $6.12M | ﹤0.01% |
70,438
-33,330
| -32% | -$2.8M |
|
1124
California Resources
CRC
$4.64B
| $6.11M | ﹤0.01% |
158,684
+13,650
| +9% | +$565K |
|
1125
LGI Homes
LGIH
$1.42B
| $6.1M | ﹤0.01% |
53,500
-9,011
| -14% | -$978K |
|
Similar funds
Deutsche Bank's Q1 2023 Portfolio in Review
As of Q1 2023, Deutsche Bank held 4,108 positions worth $180B, up 3.3% from $174B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Deutsche Bank's Q1 2023 filing shows 107 new, 2,348 increased, 1,021 reduced and 198 closed positions. Its largest new stake was GE HealthCare: 806,088 shares worth $66.1M. The largest sale was Linde, an estimated $1.33B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q1 2023 buy was GE HealthCare: 806,088 shares worth $66.1M.
- Deutsche Bank added most to Microsoft in Q1 2023, an estimated $617M increase.
- Deutsche Bank's biggest Q1 2023 reduction was Linde, cutting an estimated $1.33B.
- Deutsche Bank fully exited SVB Financial Group in Q1 2023, selling an estimated $139M.
- Deutsche Bank's ten largest holdings make up 20% of its $180B portfolio in Q1 2023.
- Deutsche Bank opened 107 new positions and closed 198 in Q1 2023.
- Deutsche Bank's portfolio value rose 3.3% quarter-over-quarter to $180B.
Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.